GO:0140346 phosphatidylserine flippase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140346 phosphatidylserine flippase activity describes ATP-dependent movement of phosphatidylserine from the exoplasmic to the cytosolic leaflet of a membrane.
• This activity is essential for maintaining the asymmetric distribution of phospholipids in the plasma membrane, a hallmark of healthy cells.
• Loss of phosphatidylserine flippase activity leads to phosphatidylserine exposure on the cell surface, a signal for apoptosis, blood coagulation, and immune clearance [1,4].
• Key genes encoding phosphatidylserine flippases include ATP11A, ATP11C, and other P4-ATPases, which are often regulated by CDC50 family chaperones [3,8].
• Reduced flippase activity is implicated in senescent erythrocytes, hereditary hemolytic anemia, cancer, and thrombotic disorders [2,5,6,7,8].
• CRISPR-based knockout, point mutation, and knock-in models are powerful tools to dissect the causal role of flippase genes in health and disease.
Description
Phosphatidylserine flippase activity (GO:0140346) is a molecular function that catalyzes the ATP-dependent translocation of phosphatidylserine (PS) from the exoplasmic leaflet to the cytosolic leaflet of cellular membranes. This activity is critical for establishing and maintaining the asymmetric distribution of phospholipids across the plasma membrane, a fundamental feature of eukaryotic cells. Under normal conditions, PS is confined to the inner leaflet, but its exposure on the outer surface serves as a potent signal for various physiological and pathological processes, including apoptosis, blood coagulation, and immune recognition [1,4]. The importance of phosphatidylserine flippase activity extends to diverse biological contexts. In erythrocytes, sustained flippase activity prevents premature PS exposure and subsequent clearance by macrophages, while its decline contributes to senescence and anemia [2,8]. In platelets, maintaining flippase activity limits procoagulant surface exposure and thrombin generation, highlighting its role in hemostasis. In cancer cells, altered flippase activity can lead to elevated external PS, which may influence immune evasion and tumor progression. Given its broad impact, researchers are actively investigating the molecular players and regulatory mechanisms of phosphatidylserine flippase activity. This article provides a comprehensive overview of the ontology, key genes, disease associations, and cutting-edge research methods, including CRISPR-based models, to study this essential function.
phosphatidylserine flippase activity At A Glance
| GO ID | GO:0140346 |
|---|---|
| GO term | phosphatidylserine flippase activity |
| Ontology | molecular_function |
| Synonym | phosphatidylserine flippase activity (exoplasmic to cytosolic leaflet) |
| Major function | ATP-dependent translocation of phosphatidylserine from the exoplasmic to the cytosolic leaflet of a membrane |
| Cellular location | Plasma membrane and other organelle membranes |
| Representative genes | ATP11A, ATP11C, ATP8A1, ATP8B1, and CDC50 family chaperones |
| Associated diseases | Hereditary hemolytic anemia, cancer, thrombosis, and senescence-related disorders |
| Research methods | CRISPR knockout/knock-in, lipid asymmetry assays, fluorescence microscopy, and biochemical transport assays |
What Is GO:0140346?
Phosphatidylserine flippase activity (GO:0140346) is defined as the catalysis of the movement of phosphatidylserine from the exoplasmic to the cytosolic leaflet of a membrane, using energy from the hydrolysis of ATP. This activity is a type of ATP-dependent phospholipid transporter that specifically recognizes phosphatidylserine and flips it against its concentration gradient, thereby maintaining membrane lipid asymmetry.
Why Is phosphatidylserine flippase activity Important in Cell Biology?
Phosphatidylserine flippase activity is fundamentally important because it maintains the asymmetric distribution of phospholipids in the plasma membrane, which is essential for cell survival, signaling, and interactions with the environment. Disruption of this activity leads to phosphatidylserine exposure, a key signal for apoptosis and immune clearance, and is implicated in a wide range of diseases including anemia, cancer, and thrombosis [1,4,8].
• Maintains membrane lipid asymmetry, a hallmark of healthy eukaryotic cells.
• Prevents premature phosphatidylserine exposure that triggers blood coagulation and thrombosis.
• Regulates apoptotic cell clearance by macrophages; loss of flippase activity is a signal for phagocytosis.
• Its decline contributes to erythrocyte senescence and hereditary hemolytic anemia [2,8].
• Altered flippase activity in cancer cells leads to elevated surface phosphatidylserine, potentially affecting immune surveillance.
• Plays a role in platelet procoagulant activity and thrombin generation.
• Is regulated by intracellular calcium and tubulin, linking it to hypertension and diabetes.
• Serves as a target for therapeutic intervention in thrombotic and hemolytic disorders [6,8].
• Provides a model system to study ATP-driven lipid transport and membrane dynamics.
• CRISPR-based editing of flippase genes enables causal studies in human cell models.
Mechanism, Genes and Research Methods of phosphatidylserine flippase activity
Substrate Recognition and Binding
In simple terms: The flippase enzyme first grabs onto phosphatidylserine on the outside of the cell membrane.
Phosphatidylserine flippases, primarily P4-ATPases, specifically recognize phosphatidylserine (PS) in the exoplasmic leaflet of the lipid bilayer. This recognition is mediated by the transmembrane domains of the flippase, which form a binding pocket for the polar headgroup of PS. The binding is energy-independent and precedes ATP hydrolysis.
ATP Hydrolysis and Conformational Change
In simple terms: The enzyme uses ATP as fuel to change its shape and flip the lipid across the membrane.
Upon substrate binding, the flippase hydrolyzes ATP, which drives a conformational change that translocates PS from the exoplasmic to the cytosolic leaflet. This process is coupled to the phosphorylation and dephosphorylation of the enzyme, typical of P-type ATPases. The energy from ATP hydrolysis is used to overcome the concentration gradient of PS.
Lipid Translocation and Membrane Asymmetry
In simple terms: The lipid is moved to the inside, keeping the outer surface free of phosphatidylserine.
The flippase moves PS across the membrane, contributing to the maintenance of lipid asymmetry. This activity ensures that PS remains predominantly in the cytosolic leaflet under normal conditions. Loss of this activity results in PS exposure on the cell surface, which can be detected by annexin V binding [1,4].
Regulation by CDC50 Chaperones
In simple terms: Helper proteins called CDC50 are needed for the flippase to work properly.
P4-ATPases require association with CDC50 family proteins (also known as TMEM30A/B) for proper folding, ER exit, and catalytic activity. The CDC50 subunit acts as a chaperone and is essential for the flippase to reach the plasma membrane and function. Mutations in either subunit can abolish flippase activity.
Calcium and Tubulin Regulation
In simple terms: Calcium levels and the cytoskeleton can turn flippase activity up or down.
Intracellular calcium and tubulin modulate phosphatidylserine flippase activity. Elevated calcium inhibits flippase activity, contributing to PS exposure in activated platelets and cancer cells [5,7]. Tubulin binding also inhibits flippase-like activity in erythrocytes from hypertensive and diabetic patients.
Key Genes Involved in GO:0140346 phosphatidylserine flippase activity
The following genes encode proteins that directly mediate or regulate phosphatidylserine flippase activity, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATP11A | P4-ATPase flippase that translocates PS across the plasma membrane | Implicated in cancer and apoptosis; target for CRISPR knockout studies [3,7] |
| ATP11C | P4-ATPase flippase essential for PS asymmetry in erythrocytes | Mutations cause hereditary hemolytic anemia; model for point mutation studies |
| ATP8A1 | P4-ATPase flippase involved in PS transport in various tissues | Studied for its role in membrane asymmetry and vesicle trafficking |
| ATP8B1 | P4-ATPase flippase associated with cholestasis | Relevant to liver disease and membrane asymmetry |
| CDC50A (TMEM30A) | Chaperone subunit for P4-ATPases | Required for flippase function; knockout abolishes PS flippase activity |
| CDC50B (TMEM30B) | Chaperone subunit for P4-ATPases | Modulates flippase specificity and localization |
| XKR8 | Scramblase that exposes PS during apoptosis | Opposes flippase activity; studied in apoptosis [1,4] |
| TMEM16F (ANO6) | Calcium-activated scramblase | Mediates PS exposure in platelets and other cells |
| PIEZO1 | Mechanosensitive channel linked to PS exposure in erythrocytes | Potential regulator of flippase activity |
| ABC1 (ABCA1) | Lipid transporter affecting membrane asymmetry | Indirectly influences PS distribution |
| SLC44A1 | Choline transporter-like protein | May affect phospholipid metabolism and flippase function |
| ATP11B | P4-ATPase flippase | Less characterized; potential role in PS transport |
| ATP10A | P4-ATPase flippase | Associated with metabolic traits; understudied |
| ATP10D | P4-ATPase flippase | Implicated in lipid metabolism |
| ATP9A | P4-ATPase flippase | Involved in endosomal trafficking |
| ATP9B | P4-ATPase flippase | Regulates membrane dynamics |
| CCT5 | Chaperonin subunit | May interact with flippases; not directly a flippase |
| HSPA8 | Heat shock protein | Chaperone that may assist flippase folding |
How Is phosphatidylserine flippase activity Regulated?
Phosphatidylserine flippase activity is regulated at multiple levels. Intracellular calcium inhibits flippase activity, while scramblases such as TMEM16F and XKR8 are activated by calcium to expose PS. Tubulin binding inhibits flippase-like activity in erythrocytes, linking cytoskeletal dynamics to lipid asymmetry. In platelets, maintaining flippase activity is a novel approach to reducing thrombin generation, suggesting that pharmacological or genetic modulation of flippase activity can regulate coagulation. Additionally, the expression and localization of P4-ATPases are controlled by CDC50 chaperones, and mutations in these subunits can lead to loss of function [3,8].
phosphatidylserine flippase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATP11C | Hereditary hemolytic anemia | Knock-in of patient missense variant in erythroid cell line |
| ATP11A | Cancer progression and immune evasion | Knockout in cancer cell lines followed by annexin V staining |
| TMEM16F | Scott syndrome (bleeding disorder) | Point mutation knock-in in platelets or megakaryocytes |
| XKR8 | Apoptosis and autoimmune clearance | Knockout in Jurkat cells to study PS exposure |
| CDC50A | Embryonic lethality and membrane asymmetry defects | Conditional knockout in mouse models |
Hereditary Hemolytic Anemia
Mutations in ATP11C, a phosphatidylserine flippase, cause reduced flippase activity in red blood cells and are associated with mild hereditary hemolytic anemia. This highlights the critical role of PS asymmetry in erythrocyte survival and function.
Cancer and Immune Evasion
Cancer cells often exhibit elevated external phosphatidylserine due to altered flippase activity and intracellular calcium levels. This PS exposure can suppress immune responses and promote tumor progression, making flippase activity a potential therapeutic target.
Thrombosis and Coagulation Disorders
In platelets, loss of flippase activity leads to PS exposure and increased thrombin generation, contributing to thrombosis. Maintaining flippase activity is therefore a novel strategy to reduce procoagulant platelet activity.
Senescence and Metabolic Disorders
Reduced flippase activity contributes to surface PS presentation in senescent erythrocytes. In hypertensive and diabetic patients, tubulin-mediated inhibition of flippase-like activity may exacerbate PS exposure, linking metabolic stress to altered lipid asymmetry.
From phosphatidylserine flippase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ATP11C cause PS exposure in erythrocytes? | CRISPR knockout of ATP11C in HUDEP-2 cells |
| How does a patient missense variant affect flippase activity? | Point mutation knock-in of ATP11C variant in K562 cells |
| Can restoring flippase activity reduce thrombin generation? | Overexpression of ATP11A in platelets or megakaryocytes |
| What is the role of CDC50A in flippase trafficking? | Tagged knock-in of CDC50A with GFP in HeLa cells |
| Does calcium regulate flippase activity in cancer cells? | Knockout of TMEM16F in cancer cells with calcium modulation |
| How does tubulin inhibit flippase activity? | Point mutation of tubulin-binding site in ATP11C |
How to Study the phosphatidylserine flippase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Annexin V flow cytometry | Phosphatidylserine exposure on cell surface | Apoptosis, platelet activation, cancer [1,4] |
| NBD-PS transport assay | Flippase-mediated lipid translocation | Kinetic analysis of flippase activity |
| CRISPR knockout | Loss-of-function phenotype | Causal gene studies |
| CRISPR point mutation knock-in | Effect of specific amino acid changes | Disease variant modeling |
| ATPase activity assay | ATP hydrolysis rate | Enzymatic characterization |
| Immunofluorescence | Subcellular localization of flippases | Trafficking and assembly studies |
| Co-immunoprecipitation | Protein-protein interactions (e.g., CDC50) | Chaperone association |
| Lipidomics | Membrane lipid composition | Global changes in lipid asymmetry |
Annexin V Binding Assay
Annexin V binding is a standard method to detect phosphatidylserine exposure on the cell surface, reflecting loss of flippase activity [1,4]. This assay can be coupled with flow cytometry to quantify PS externalization in live cells.
Fluorescent Lipid Analogs
Fluorescently labeled phosphatidylserine analogs, such as NBD-PS, are used to measure flippase activity in vitro by monitoring their translocation across the membrane. This method allows real-time kinetic analysis of flippase function.
CRISPR-Cas9 Genome Editing
CRISPR-Cas9 is used to generate knockout, point mutation, and knock-in models of flippase genes to study their function and disease relevance. These models enable causal interrogation of specific residues and domains.
Biochemical ATPase Assays
ATP hydrolysis by flippases can be measured using colorimetric or luminescent assays to assess catalytic activity. This is often combined with lipid transport assays to correlate ATPase activity with PS flipping.
How CRISPR Can Be Used to Study GO:0140346 phosphatidylserine flippase activity
Knockout
CRISPR knockout of flippase genes such as ATP11A or ATP11C abolishes phosphatidylserine flippase activity, leading to PS exposure and cellular phenotypes. These models are essential to establish causality between gene loss and disease-like features.
Point Mutation
Point mutation knock-in of patient-specific variants, such as the ATP11C missense mutation associated with hemolytic anemia, allows precise modeling of disease mechanisms and assessment of flippase activity.
Knock-in
Knock-in of tagged flippases (e.g., GFP-ATP11C) enables live-cell imaging and proteomic analysis of flippase localization and interactions. This approach is valuable for studying trafficking and regulation.
Overexpression
Overexpression of flippases such as ATP11A can enhance PS internalization and reduce procoagulant activity in platelets, offering a potential therapeutic strategy. Overexpression models help test gain-of-function effects.
How EDITGENE Supports phosphatidylserine flippase activity Research
Researchers studying phosphatidylserine flippase activity-related genes often need to determine whether a candidate gene is causally involved in maintaining lipid asymmetry or in disease-associated PS exposure. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for phosphatidylserine flippase activity research.
Frequently Asked Questions About phosphatidylserine flippase activity
What is phosphatidylserine flippase activity?
Phosphatidylserine flippase activity (GO:0140346) is the ATP-dependent movement of phosphatidylserine from the exoplasmic to the cytosolic leaflet of a membrane, maintaining lipid asymmetry.
What genes are involved in phosphatidylserine flippase activity?
Key genes include ATP11A, ATP11C, ATP8A1, ATP8B1, and CDC50 family chaperones such as CDC50A [3,8].
What diseases are associated with reduced phosphatidylserine flippase activity?
Reduced activity is linked to hereditary hemolytic anemia, cancer, thrombosis, and erythrocyte senescence [2,6,7,8].
How is phosphatidylserine flippase activity measured?
Common methods include annexin V binding, fluorescent lipid analogs like NBD-PS, and ATPase assays [1,3].
What is the role of ATP11C in phosphatidylserine flippase activity?
ATP11C is a P4-ATPase that flips PS in erythrocytes; mutations cause reduced flippase activity and hemolytic anemia.
How does calcium affect phosphatidylserine flippase activity?
Elevated intracellular calcium inhibits flippase activity and activates scramblases, leading to PS exposure [4,5].
Can CRISPR be used to study phosphatidylserine flippase activity?
Yes, CRISPR knockout, point mutation, and knock-in models are powerful tools to dissect flippase gene function and disease variants.
What is the difference between flippase and scramblase?
Flippases use ATP to move PS inward, while scramblases facilitate bidirectional PS movement and are often calcium-activated.
Why is phosphatidylserine exposure important in apoptosis?
PS exposure on the outer leaflet signals for macrophage clearance of apoptotic cells, a process regulated by flippase inactivation and scramblase activation.
What cell models are used to study phosphatidylserine flippase activity?
Common models include erythroid cells (HUDEP-2, K562), platelets, cancer cell lines, and CRISPR-edited HeLa or HEK293 cells [3,8].
Conclusion
Phosphatidylserine flippase activity (GO:0140346) is a fundamental molecular function that maintains membrane lipid asymmetry and prevents inappropriate PS exposure. Its dysregulation is implicated in a spectrum of diseases, from hemolytic anemia to cancer and thrombosis. Advances in CRISPR-based genome editing and biochemical assays continue to unravel the complex regulation and therapeutic potential of flippases. EDITGENE offers comprehensive services to support researchers in this rapidly evolving field.
References
- 1. Nagata S. 2018. Apoptosis and Clearance of Apoptotic Cells.. Annu Rev Immunol 36:489-517 PMID: 29400998
- 2. Seki M et al.. 2020. Reduction in flippase activity contributes to surface presentation of phosphatidylserine in human senescent erythrocytes.. J Cell Mol Med 24(23):13991-14000 PMID: 33103382
- 3. Sakuragi T et al.. 2023. Regulation of phospholipid distribution in the lipid bilayer by flippases and scramblases.. Nat Rev Mol Cell Biol 24(8):576-596 PMID: 37106071
- 4. Nagata S et al.. 2020. Flippase and scramblase for phosphatidylserine exposure.. Curr Opin Immunol 62:31-38 PMID: 31837595
- 5. Muhlberger T et al.. 2021. Inhibition of flippase-like activity by tubulin regulates phosphatidylserine exposure in erythrocytes from hypertensive and diabetic patients.. J Biochem 169(6):731-745 PMID: 33576821
- 6. Millington-Burgess SL et al.. 2022. Maintaining flippase activity in procoagulant platelets is a novel approach to reducing thrombin generation.. J Thromb Haemost 20(4):989-995 PMID: 35034417
- 7. Vallabhapurapu SD et al.. 2015. Variation in human cancer cell external phosphatidylserine is regulated by flippase activity and intracellular calcium.. Oncotarget 6(33):34375-88 PMID: 26462157
- 8. van Dijk MJ et al.. 2023. A novel missense variant in ATP11C is associated with reduced red blood cell phosphatidylserine flippase activity and mild hereditary hemolytic anemia.. Am J Hematol 98(12):1877-1887 PMID: 37671681
